DORC has a range of products closely developed with surgeons including:
Backing DORC’s transition to a professionally managed business
We offered significant support to DORC in its transformation from an instrument manufacturer to a global machine and consumables business operating in a compelling razor/razorblade model.
During our investment DORC continued its global expansion and established leading position in key European markets and the US. Significant investments were made to drive new product development and maintain technological leadership, as well as grow, improve and professionalise operations.
In 2019, we sold DORC to a European private equity fund Eurazeo.
Backing DORC’s transition to a professionally managed business
We offered significant support to DORC in its transformation from an instrument manufacturer to a global machine and consumables business operating in a compelling razor/razorblade model.
During our investment DORC continued its global expansion and established leading position in key European markets and the US. Significant investments were made to drive new product development and maintain technological leadership, as well as grow, improve and professionalise operations.
In 2019, we sold DORC to a European private equity fund Eurazeo.
Location: Netherlands
Investors 2
| Date | Name | Website |
| 09.11.2020 | Montagu Pr... | montagu.co... |
| - | Eurazeo | eurazeo.co... |
Mentions in press and media 1
| Date | Title | Description |
| 27.03.2025 | ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach | JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administrati... |